Serum LAIR-2 Is Increased in Autoimmune Thyroid Diseases

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Simone, Rita ^a,b   Pesce, Giampaola ^c   Antola, Princey ^c   Merlo, Domenico F ^d   Bagnasco, Marcello ^c   Saverino, Daniele ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; LEUKOCYTE ASSOCIATED IMMUNOGLOBULIN LIKE RECEPTOR; LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; BINDING AFFINITY; CLINICAL FEATURE; CONTROLLED STUDY; EYE DISEASE; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IN VITRO STUDY; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL;

ADULT; COLLAGEN; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; THYROIDITIS, AUTOIMMUNE; YOUNG ADULT;

EID: 84877771838     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063282     Document Type: Article

References (18)

1. Lenschow DJ, Walunas TL, Blueston JA, (1966) CD28/B7 system of T cell costimulation. Ann Rev Immunol 14: 233-258.
2. Greenwald RJ, Freeman GJ, Sharpe AH, (2005) The B7 family revisited. Annu Rev Immunol 23: 515-548.
3. Levine SJ, (2004) Mechanisms of soluble cytokine receptor generation. J Immunol 173: 343-5348.
4. Saverino D, Brizzolara R, Simone R, Chiappori A, Milintenda-Floriani F, et al. (2007) Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation. Clin Immunol 123: 190-198.
5. Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, et al. (1997) LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 7: 283-290.
6. Lebbink RJ, Raynal N, de Ruiter T, Bihan DG, Farndale RW, et al. (2009) Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III. Matrix Biol 28: 202-210.
7. Olde Nordkamp MJ, van Roon JA, Douwes M, de Ruiter T, Urbanus RT, et al. (2011) Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) and soluble LAIR-1 in rheumatoid arthritis: LAIR-2 is a more efficient antagonist of the LAIR-1-collagen inhibitory interaction than is soluble LAIR-1. Arthritis Rheum 63: 3749-3757.
8. Meyaard L, Hurenkamp J, Clevers H, Lanier LL, Phillips JH, (1999) Leukocyte-associated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells. J Immunol 162: 5800-5804.
9. Lebbink RJ, De Ruiter T, Adelmeijer J, Brenkman AB, van Helvoort JM, et al. (2006) Collagens are functional, high-affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 203: 1419-1425.
10. Merlo A, Tenca C, Fais F, Battini L, Ciccone E, et al. (2005) Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes. Clin Diagn Lab Immunol 1: 705-712.
11. Lebbink RJ, van den Berg MC, de Ruiter T, Raynal N, van Roon JA, et al. (2008) The soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the collagen/LAIR-1 inhibitory immune interaction. J Immunol 180: 1662-1669.
12. Díaz-Peña R, Aransay AM, Suárez-Álvarez B, Bruges-Armas J, Rodríguez-Ezpeleta N, et al. (2012) A high density SNP genotyping approach within the 19q13 chromosome region identifies an association of a CNOT3 polymorphism with ankylosing spondylitis. Ann Rheum Dis 71: 714-717.
13. Ouyang W, Xue J, Liu J, Jia W, Li Z, et al. (2004) Establishment of an ELISA system for determining soluble LAIR-1 levels in sera of patients with HFRS and kidney transplant. J Immunol Methods 29: 109-117.
14. Welch BL, (1947) The generalization of "Student's" problem when several different population variances are involved. Biometrika 34: 28-35.
15. Myllyharju J, Kivirikko KI, (2004) Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet 20: 33-43.
16. De Bellis A, Sansone D, Coronella C, Conte M, Iorio S, et al. (2005) Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy. Clin Endocrinol 62: 24-29.
17. Founds SA, Fallert-Junecko B, Reinhart TA, Conley YP, Parks WT, (2010) LAIR2 localizes specifically to sites of extravillous trophoblast invasion. Placenta 31: 880-885.
18. Lenting PJ, Westerlaken GH, Denis CV, Akkerman JW, Meyaard L, (2010) Efficient inhibition of collagen-induced platelet activation and adhesion by LAIR-2, a soluble Ig-like receptor family member. PLoS One 5: e12174.